Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 15,418 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Abeona Therapeutics Inc | ABEO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 1.25% | 3.23 | 08:58:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.19 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 110 | 15,418 | - | 2.83 - 9.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:03:00 | 12 | $ 3.2449 | USD |
Abeona Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 79.03M | 24.77M | - | 4.57M | -54.19M | -2.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Abeona Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABEO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.50 | 7.73 | 3.05 | 3.87 | 2,035,186 | -4.27 | -56.93% |
| 1 Month | 7.22 | 8.45 | 3.05 | 4.79 | 705,538 | -3.99 | -55.26% |
| 3 Months | 4.24 | 9.01 | 3.05 | 6.09 | 505,699 | -1.01 | -23.82% |
| 6 Months | 3.89 | 9.01 | 3.05 | 5.68 | 344,761 | -0.66 | -16.97% |
| 1 Year | 3.23 | 9.01 | 2.83 | 5.15 | 245,092 | 0.00 | 0.00% |
| 3 Years | 1.60 | 9.01 | 0.1303 | 1.31 | 895,703 | 1.63 | 101.88% |
| 5 Years | 8.24 | 9.01 | 0.1303 | 1.97 | 1,208,746 | -5.01 | -60.80% |
Abeona Therapeutics Description
| Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. |
